Andrew Vick

779 total citations
17 papers, 608 citations indexed

About

Andrew Vick is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Andrew Vick has authored 17 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Andrew Vick's work include Parathyroid Disorders and Treatments (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatic function and diabetes (3 papers). Andrew Vick is often cited by papers focused on Parathyroid Disorders and Treatments (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatic function and diabetes (3 papers). Andrew Vick collaborates with scholars based in United States, United Kingdom and Australia. Andrew Vick's co-authors include Wolfgang Glaesner, Martin Brenner, Yu Tian, Anja Köester, Niels Pörksen, Rohn Millican, Bernice Ellis, Garret J. Etgen, Krister Bokvist and William L. Hayton and has published in prestigious journals such as Kidney International, Journal of Pharmaceutical Sciences and Clinical Pharmacokinetics.

In The Last Decade

Andrew Vick

16 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Vick United States 13 235 229 144 69 67 17 608
Shao Zhong China 13 182 0.8× 165 0.7× 76 0.5× 43 0.6× 85 1.3× 56 633
Tanu Soni United States 14 102 0.4× 300 1.3× 69 0.5× 81 1.2× 142 2.1× 24 667
Takayuki Sasahara Japan 13 328 1.4× 179 0.8× 198 1.4× 48 0.7× 111 1.7× 22 1.1k
Daisuke Mikami Japan 14 94 0.4× 334 1.5× 71 0.5× 56 0.8× 153 2.3× 30 593
Batya Gayer Israel 15 133 0.6× 232 1.0× 38 0.3× 63 0.9× 46 0.7× 33 792
Audrey Aguesse France 15 109 0.5× 255 1.1× 163 1.1× 39 0.6× 165 2.5× 29 612
Konstantin Seferiadis Greece 12 87 0.4× 268 1.2× 81 0.6× 51 0.7× 90 1.3× 22 553
Joanna Bober Poland 12 73 0.3× 185 0.8× 115 0.8× 54 0.8× 44 0.7× 61 529
Fei Ye China 18 81 0.3× 330 1.4× 99 0.7× 46 0.7× 52 0.8× 40 820
J Makowski United States 3 140 0.6× 257 1.1× 91 0.6× 24 0.3× 139 2.1× 4 697

Countries citing papers authored by Andrew Vick

Since Specialization
Citations

This map shows the geographic impact of Andrew Vick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Vick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Vick more than expected).

Fields of papers citing papers by Andrew Vick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Vick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Vick. The network helps show where Andrew Vick may publish in the future.

Co-authorship network of co-authors of Andrew Vick

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Vick. A scholar is included among the top collaborators of Andrew Vick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Vick. Andrew Vick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Havenaar, R., et al.. (2016). Increased bioavailability of celecoxib under fed versus fasted conditions is determined by postprandial bile secretion as demonstrated in a dynamic gastrointestinal model. Drug Development and Industrial Pharmacy. 42(8). 1334–1339. 19 indexed citations
3.
Yu, Rosie Z., John S. Grundy, Scott P. Henry, et al.. (2015). Predictive Dose-Based Estimation of Systemic Exposure Multiples in Mouse and Monkey Relative to Human for Antisense Oligonucleotides With 2′-O-(2-Methoxyethyl) Modifications. Molecular Therapy — Nucleic Acids. 4. e218–e218. 38 indexed citations
4.
Rix, Peter J., Andrew Vick, Geoffrey E. Barker, et al.. (2014). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Nebulized Sodium Nitrite (AIR001) Following Repeat-Dose Inhalation in Healthy Subjects. Clinical Pharmacokinetics. 54(3). 261–272. 43 indexed citations
5.
Shen, Jun, Jim Xiao, Saling Huang, et al.. (2014). A pharmacokinetic/pharmacodynamic model for AMG 416, a novel calcimimetic peptide, following a single intravenous dose in healthy subjects. The Journal of Clinical Pharmacology. 54(10). 1125–1133. 12 indexed citations
6.
Vick, Andrew. (2014). Antibiotics for lower urinary tract infection in children.. PubMed. 110(6). 22–22.
7.
Martin, Kévin, Saling Huang, Geoffrey A. Block, et al.. (2013). AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients. Kidney International. 85(1). 191–197. 53 indexed citations
8.
Vick, Andrew. (2013). Clinically indicated replacement versus routine replacement of peripheral venous catheters. International Journal of Evidence-Based Healthcare. 11(4). 339–340. 2 indexed citations
9.
Shen, Jun, et al.. (2012). Implementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model). Journal of Pharmacokinetics and Pharmacodynamics. 39(3). 251–262. 22 indexed citations
10.
Glaesner, Wolfgang, Andrew Vick, Rohn Millican, et al.. (2010). Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein. Diabetes/Metabolism Research and Reviews. 26(4). 287–296. 231 indexed citations
11.
Vaughn, Daniel E., Richard C. Yocum, Douglas B. Muchmore, et al.. (2009). Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase. Diabetes Technology & Therapeutics. 11(6). 345–352. 41 indexed citations
12.
13.
Kohn, Wayne D., Radmila Micanovic, Sharon L. Myers, et al.. (2007). pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity. Peptides. 28(4). 935–948. 40 indexed citations
14.
Vick, Andrew, et al.. (2006). Pharmacokinetics and Hepatic Extraction of Recombinant Human Parathyroid Hormone, hPTH (1–34), in Rat, Dog, and Monkey. Journal of Pharmaceutical Sciences. 95(11). 2499–2506. 9 indexed citations
15.
Vick, Andrew & William L. Hayton. (2001). Methyltestosterone pharmacolinetics and oral bioavailability in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology. 52(3-4). 177–188. 16 indexed citations
16.
Schultz, Irvin R., Mace G. Barron, Michael C. Newman, & Andrew Vick. (1999). Blood flow distribution and tissue allometry in channel catfish. Journal of Fish Biology. 54(6). 1275–1286. 27 indexed citations
17.
Hayton, William L., et al.. (1996). Disposition of benzocaine in channel catfish. Aquatic Toxicology. 36(1-2). 99–113. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026